FeesSafety
Pluang+

onsemi acquires Ferric for $600M to lead power delivery in AI processors, boosting 2030 AI data center revenue target to $3B+

Company Fundamentals
02 Nov 2026, 23:05 WIB
GlobeNewsWire
View Source
Bullish
onsemi acquires Ferric for $600M to lead power delivery in AI processors, boosting 2030 AI data center revenue target to $3B+

onsemi announced it will acquire Ferric, a leader in integrated voltage regulator (IVR) technology, for $600 million plus up to $175 million in contingent payments. This acquisition strengthens onsemi's position in power delivery for next-generation AI processors by combining Ferric's advanced IVR tech and engineering talent with onsemi's scale and customer base. The deal raises onsemi's 2030 AI data center revenue target by $500 million to over $3 billion and is expected to accelerate growth in its IVR business. The transaction is expected to close by the end of 2026 and will be accretive to onsemi's long-term revenue, margins, and earnings per share targets.

The story about onsemi's acquisition of Ferric is presented here with relevant market data for context. For readers following the Technology sector, 38 out of 150 US stocks rose while 111 fell. Notable movers include FIRY at USD 13.28 with an 8.06% gain, CRSR at USD 12.62 down 8.05% but with 100% buy orders, and UMC at USD 16.68 down 7.54% with 99% buy orders. This snapshot is as of Nov 03, 2026 04:11 WIB.

More News

Zentalis grants 136,000 stock options to new hires under Nasdaq inducement rule

Zentalis grants 136,000 stock options to new hires under Nasdaq inducement rule

Zentalis Pharmaceuticals awarded 136,000 non-qualified stock options to four newly hired employees as an inducement to join the company, under Nasdaq Listing Rule 5635(c)(4). The options have an exercise price of $1.85, matching the stock's closing p...

Company Fundamentals
Neutral
1 hour ago
Dianthus Therapeutics grants stock options to new hires under Nasdaq inducement rule

Dianthus Therapeutics grants stock options to new hires under Nasdaq inducement rule

Dianthus Therapeutics, a clinical-stage biotech company, granted stock options to three new non-executive employees as inducements for joining the company. The options cover 26,000 shares at an exercise price of $82.25, vesting over four years. This ...

Company Fundamentals
Neutral
1 hour ago
Federal Home Loan Bank of Atlanta elects new directors and appoints 2027 Chair and Vice Chair.

Federal Home Loan Bank of Atlanta elects new directors and appoints 2027 Chair and Vice Chair.

The Federal Home Loan Bank of Atlanta announced the election of three new member directors and the re-election of one independent director to its board for 2026. Suzanne DeFerie was named Chair and Kathy McKinney Vice Chair for 2027, ensuring experie...

Neutral
3 hours ago
FDA halts Bright Minds' epilepsy trial over toxicity concerns, triggering stock selloff and investor investigation

FDA halts Bright Minds' epilepsy trial over toxicity concerns, triggering stock selloff and investor investigation

The FDA placed Bright Minds Biosciences' planned Phase 2 epilepsy trial for BMB-101 on partial clinical hold due to toxicity findings in mice and insufficient pharmacokinetic and juvenile-toxicity data. This action caused a sharp decline in the compa...

Market News
Bearish
5 hours ago
NEAR governance cuts max annual token issuance from 2.5% to 1.6%, lowering staking rewards.

NEAR governance cuts max annual token issuance from 2.5% to 1.6%, lowering staking rewards.

NEAR governance approved a plan to reduce the maximum annual issuance of the NEAR token from 2.5% to 1.6%. This change aims to slow the rate at which new tokens enter circulation, potentially impacting staking rewards by lowering them. The plan inclu...

Protocol Fundamentals
Neutral
5 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App